Latest Articles

Publication Date
Impact of pelvic endometriosis on the chances of pregnancy in the context of oocyte donation.

Endometriosis is diagnosed in 25% to 40% of infertile patients. This disease can affect ovarian reserve and oocyte quality, as a result Assisted Reproductive Technology is often required. However, the …

Published: Nov. 27, 2025, midnight
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - The Progress Index

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis The Progress Index

Published: Nov. 26, 2025, 4:31 a.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Montgomery Advertiser

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Montgomery Advertiser

Published: Nov. 26, 2025, 1:16 a.m.
Personalized Vaginal Drug Delivery through 3D Printing: Techniques, Challenges, and Future Perspectives.

Vaginal disorders in reproductive‑age women, including bacterial vaginosis (affecting 23-29%), endometriosis, etc., are increasing alarmingly day by day worldwide. Vaginal drug delivery (VDD) has garnered notable attention in the pharmaceutical …

Published: Nov. 26, 2025, midnight
Appendiceal endometriosis: an uncommon manifestation of deep infiltrating endometriosis.

Appendiceal endometriosis is a rare cause of acute appendicitis, accounting for approximately 1% of cases.This report describes a case of a female patient presenting with right iliac fossa pain and …

Published: Nov. 26, 2025, midnight
Urine and Serum miRNA Signatures for the Non-Invasive Diagnosis of Adenomyosis: A Machine Learning-Based Pilot Study.

Background: Adenomyosis remains difficult to diagnose non-invasively due to clinical overlap with endometriosis and the limited specificity of imaging techniques. This pilot study evaluated whether serum- and urine-derived microRNA (miRNA) …

Published: Nov. 26, 2025, midnight
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Beaver County Times

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Beaver County Times

Published: Nov. 25, 2025, 9:18 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Central New Jersey News

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Central New Jersey News

Published: Nov. 25, 2025, 8:33 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - The Herald-Mail

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis The Herald-Mail

Published: Nov. 25, 2025, 6:12 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Akron Beacon Journal

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Akron Beacon Journal

Published: Nov. 25, 2025, 5:16 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!